Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

During the Trading Day
0.80 -0.02 / -2.44%
As of 4:06pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.8128 +0.0128 / +1.60%
Volume: 12.3K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues597.7K78.7K1.1M6.3M
Cost of Goods Sold----332.8K1.6M
Depreciation And Amortization176.5K200.2K404.2K500.2K
Operating ExpensesGross Income----393.6K4.2M
General Expenses24.5M27.9M38.8M31.2M
Research And Development15.2M16.9M23.7M16.8M
Total Operating Expenses24.7M28.1M39.6M33.3M
Non-Operating ExpensesOperating Income-24.1M-28.0M-38.4M-27.0M
Extraordinary Credit0.0032.1K0.00--
Extraordinary Charge-952.4K---1.5M-4.6M
Pre-Tax Equity Earnings0.00-----523.8K
Interest Expense On Debt13.3K1.2M2.8M3.7M
Other Expenses-3.2K-58.7K-16.9K72.7K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.0M-29.2M-42.7M-35.7M
Income Taxes-7.9M0.000.000.00
Preferred Dividend-100.0K-43.3K0.000.00
Discontinued Operations3.3M0.000.000.00
Extraordinary Items19.5M0.000.000.00
Net Income-13.8M-29.2M-42.7M-35.7M
Shares To Calculate EPSShares To Calculate EPS90.5M99.1M121.8M148.7M
Shares To Calculate EPS Diluted90.5M99.1M121.8M148.7M
Earnings Per ShareEPS$0.06-$0.29-$0.35-$0.24
EPS Diluted-$0.15-$0.29-$0.35-$0.24